Copyright
©The Author(s) 2025.
World J Clin Oncol. Feb 24, 2025; 16(2): 99839
Published online Feb 24, 2025. doi: 10.5306/wjco.v16.i2.99839
Published online Feb 24, 2025. doi: 10.5306/wjco.v16.i2.99839
Figure 3 Semi-quantitative evaluation of proteasome 26S subunit non-ATPase 6 protein expression in hepatocellular carcinoma and non-hepatocellular carcinoma tissues.
A and B: Semi-quantitative comparison of proteasome 26S subunit non-ATPase 6 (PSMD6) protein expression levels between HCC tissues and non-HCC tissues from institutions; C and D: Evaluation of the ability of highly expressed PSMD6 from institutions A and B to identify HCC tissues. HCC: Hepatocellular carcinoma; PSMD6: Proteasome 26S subunit non-ATPase 6.
- Citation: Zhou SS, Ye YP, Chen Y, Zeng DT, Zheng GC, He RQ, Chi BT, Wang L, Lin Q, Su QY, Dang YW, Chen G, Wei JL. Overexpression pattern, function, and clinical value of proteasome 26S subunit non-ATPase 6 in hepatocellular carcinoma. World J Clin Oncol 2025; 16(2): 99839
- URL: https://www.wjgnet.com/2218-4333/full/v16/i2/99839.htm
- DOI: https://dx.doi.org/10.5306/wjco.v16.i2.99839